ampicillin has been researched along with Disbacteriosis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 9 (60.00) | 2.80 |
Authors | Studies |
---|---|
Feng, S; Huang, C; Huo, F; Liu, H | 1 |
Alcantar, MA; Avila-Pacheco, J; Cárdenas, P; Collins, JJ; Cubillos-Ruiz, A; Donghia, NM | 1 |
Ariki, S; Chalalai, T; Dewayani, A; Fujitsuka, N; Fukuda, C; Hidano, S; Ishizawa, S; Ito, K; Kamiyama, N; Kobayashi, T; Kubota, K; Kudo, Y; Minata, M; Mizukami, K; Mogami, S; Murakami, K; Nishiyama, M; Ozaka, S; Ozaki, T; Sachi, N; Soga, Y; Sonoda, A | 1 |
Guo, MY; He, JQ; Li, XJ; Peng, QY; Wu, LR; Ying, HZ; Yu, CH | 1 |
Akhtar, S; Cosgrove, C; Dellacecca, ER; Engelhard, VH; Knight, KL; Le Poole, IC; Mukhatayev, Z; Rademaker, AW | 1 |
Althouse, MH; Jiang, W; Lingappan, K; Moorthy, B; Stewart, C | 1 |
Fengxia, M; Guangfu, Y; Qing, W; Qiyong, L; Ruiling, Z; Zhijing, X; Zhong, Z | 1 |
Kulkarni, S; Pasricha, PJ; Saha, M; Sears, CL; Sylvia, KE; Yarandi, SS | 1 |
Cheng, G; Cheng, L; Kong, L; Li, M; Ma, Y; Peng, X; Qiu, W; Ren, B; Wu, H; Zhou, X | 1 |
Banerjee, S; Mitra Mazumder, P; Roy Sarkar, S | 1 |
Fujimoto, K; Hagiwara, S; Kamata, K; Komeda, Y; Kudo, M; Minaga, K; Nishida, N; Okamoto, A; Okamoto, K; Sakamoto, H; Sakurai, T; Takenaka, M; Tanaka, T; Watanabe, T; Yamao, K | 1 |
Li, R; Lu, D; Ran, Z; Tian, M; Yang, J; Yin, J; Zhang, Y; Zhong, J; Zhou, Y | 1 |
Kim, YG; Núñez, G; Shibuya, A; Totsuka, N; Udayanga, KG; Weinberg, JB | 1 |
Kuo, WT; Lin, YD; Lu, KS; Ni, YH; Peng, WH; Shih, YA; Turner, JR; Wei, SC; Wu, LL; Yu, LC | 1 |
Fukunaga, M; Okamura, N; Tabuchi, N; Takayama, K | 1 |
15 other study(ies) available for ampicillin and Disbacteriosis
Article | Year |
---|---|
Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Dysbiosis; Gastrointestinal Microbiome; Humans; Metronidazole; Mice; Neomycin; RNA, Ribosomal, 16S; Vancomycin | 2022 |
An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Clostridioides difficile; Dysbiosis; Mice | 2022 |
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Colitis; Colitis, Ulcerative; Disease Models, Animal; Drugs, Chinese Herbal; Dysbiosis; Herbal Medicine; Inflammation; Intestinal Mucosa; Japan; Mice; Mice, Inbred C57BL; Vancomycin | 2022 |
Daqing formula ameliorated allergic asthma and airway dysbacteriosis in mice challenged with ovalbumin and ampicillin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Asthma; Dysbiosis; Glycogen Synthase Kinase 3 beta; Mice; Ovalbumin | 2024 |
Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice.
Topics: Administration, Oral; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides; Cytokines; Disease Models, Animal; DNA, Bacterial; Dysbiosis; Feces; Female; Humans; Intestinal Mucosa; Male; Mice; Microbiota; Neomycin; Pseudomonas; RNA, Ribosomal, 16S; Skin; T-Lymphocytes, Regulatory; Vitiligo | 2020 |
Impact of Early Life Antibiotic Exposure and Neonatal Hyperoxia on the Murine Microbiome and Lung Injury.
Topics: Ampicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Disease Models, Animal; Dysbiosis; Female; Gastrointestinal Microbiome; Hyperoxia; Mice; Mice, Inbred C57BL; Pregnancy; Pulmonary Alveoli; RNA, Ribosomal, 16S | 2019 |
Variation in the microbiota across different developmental stages of Aedes albopictus is affected by ampicillin exposure.
Topics: Aedes; Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Biological Control Agents; Dysbiosis; Larva; Microbiota; Mosquito Control; Pupa | 2020 |
Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice.
Topics: Adult; Ampicillin; Animals; Cells, Cultured; Colon; Disease Models, Animal; Dysbiosis; Enteric Nervous System; Gastrointestinal Microbiome; Gastrointestinal Motility; Germ-Free Life; Humans; Male; Mice; Mice, Transgenic; Myenteric Plexus; Nestin; Neurogenesis; Nitrergic Neurons; Nitric Oxide; Primary Cell Culture; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2020 |
Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Resistance; Dysbiosis; Gastrointestinal Microbiome; Mouth; Rats; RNA, Ribosomal, 16S; Salmonella Infections, Animal; Salmonella typhimurium; Vancomycin | 2020 |
Probiotics protect against gut dysbiosis associated decline in learning and memory.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Dysbiosis; Gastrointestinal Microbiome; Hippocampus; Maze Learning; Memory; Mice; Oxidative Stress; Probiotics | 2020 |
Dysbiosis-Associated Polyposis of the Colon-Cap Polyposis.
Topics: Ampicillin; Anti-Bacterial Agents; Asymptomatic Diseases; Bacteria; Colon; Colonic Polyps; Dysbiosis; Feces; Gastrointestinal Diseases; Gastrointestinal Microbiome; High-Throughput Nucleotide Sequencing; Humans; Inflammation; Male; Metronidazole; Middle Aged | 2018 |
Commensal Microbes Affect Host Humoral Immunity to
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacteroidetes; Bordetella pertussis; Dysbiosis; Female; Firmicutes; Gastrointestinal Microbiome; Immunity, Humoral; Immunity, Innate; Immunoglobulin G; Metronidazole; Mice; Mice, Inbred BALB C; Neomycin; Proteobacteria; Symbiosis; Vancomycin; Whooping Cough | 2019 |
Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.
Topics: Adoptive Transfer; Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Candida; Candidiasis; Cefoperazone; Celecoxib; Clindamycin; Cyclooxygenase Inhibitors; Dinoprostone; Dysbiosis; Feces; Gastrointestinal Tract; Inflammation; Lung; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazoles; Sulfonamides | 2014 |
Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Dysbiosis; Enterobacteriaceae Infections; Escherichia coli; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbiota; Symbiosis; Transcytosis | 2014 |
Rhein 8-O-β-D-Glucopyranoside Elicited the Purgative Action of Daiokanzoto (Da-Huang-Gan-Cao-Tang), Despite Dysbiosis by Ampicillin.
Topics: Ampicillin; Animals; Anthraquinones; Anti-Bacterial Agents; Bacteroides; Dysbiosis; Gastrointestinal Microbiome; Glycyrrhiza uralensis; Male; Mice; Monosaccharides; Plant Extracts; Rhus; Senna Extract; Sennosides | 2016 |